Site icon news.soban.in

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial (Soban News)

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.​The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. ​NYT > Business [ SOBAN NEWS: International and National ]

Exit mobile version